ANI Pharmaceuticals, Inc. (ANIP)
85.43
+0.40
(+0.47%)
USD |
NASDAQ |
Jan 15, 16:00
85.43
0.00 (0.00%)
After-Hours: 16:23
ANI Pharmaceuticals SG&A Expense (TTM): 304.67M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| CorMedix, Inc. | 75.56M |
| Arcutis Biotherapeutics, Inc. | 253.18M |
| Intellia Therapeutics, Inc. | 119.17M |
| Amicus Therapeutics, Inc. | 353.07M |
| Castle Biosciences, Inc. | 222.56M |